FDA Locally Active Drug BA/BE Guidances Slated for Release In About A Year
Executive Summary
Four FDA guidances on drug bioavailability and bioequivalence, including three focused on "locally active drug products," are expected to be issued "in the next year or so," Center for Drug Evaluation and Research Deputy Director for Pharmaceutical Science Roger Williams, MD, told an International Generic Pharmaceutical Alliance conference in Rome June 5.